Trading Briefs

GreenCell Names New Chief Financial Officer – OTC:GCLL

GreenCell Inc. (OTC:GCLL), a company involved in a joint venture with SenCer Inc. to develop, commercialize and market SenCer’s UltraTemp™ ceramic composite materials for Home and Transportation applications, recently, declared the hiring of a new Chief Financial Officer. GCLL employed … Continue reading

Posted in Trading Briefs | Tagged , , | 3 Comments

Yippy Commences Trading on OTCQX – PINK:YIPI

OTC Markets Group Inc., the firm that operates the world’s biggest electronic marketplace for OTC-traded equities, recently declared that Yippy Inc (PINK:YIPI), a provider of fast, family friendly search engine and educational reference portals, is currently trading on the OTC … Continue reading

Posted in Trading Briefs | Tagged , , | 8 Comments

Pacific City Financial Posts Q1 Financial Highlights – OTC:PFCF

Pacific City Financial Corporation (OTC:PFCF) recently announced financial results for its 2012 Q1, reporting consolidated net income of $1.8 million and net income available to common shareholders of $1.5 million, on enhancements in asset quality. Net interest income ahead of … Continue reading

Posted in Trading Briefs | Tagged , , | 2 Comments

Sound Financial Posts Ninth Consecutive Lucrative Quarter – OTC:SNFL

Sound Financial, Inc. (OTC:SNFL), holding firm for Sound Community Bank, recently announced net income for the quarter closed March 31, 2012, of $546,000, or $0.18 a diluted share, against consolidated net income of $496,000, or $0.17 a diluted share, for … Continue reading

Posted in Trading Briefs | Tagged , , | 2 Comments

Rainbow BioSciences Associate Amarantus BioSciences Announces Positive Pre-Clinical Results of Parkinson’s Treatment – OTC:RBCC

Rainbow BioSciences, LLC, the biotech subsidiary of Rainbow Coral Corporation (OTC:RBCC), declared today that its current joint venture target, Amarantus BioSciences, Inc., has attained positive results in a pre-clinical experiment representing the potential of its new Parkinson’s disease therapy presently … Continue reading

Posted in Trading Briefs | Tagged , , | 1 Comment